IVERS-READ GILLIAN C Insider Trading
Get the latest insider transactions of IVERS-READ GILLIAN C. IVERS-READ GILLIAN C is Vice President in PHARMION CORP ($PHRM) and VP, Clin. Dev. & Reg. Affairs in PHARMION CORP ($PHRM) and VP-Clinical Dev.& Reg. Affairs in PHARMION CORP ($PHRM) and Director in BIO-PATH HOLDINGS INC ($BPTH) and See Remarks in Clovis Oncology, Inc. ($CLVS). Discover the current value of IVERS-READ GILLIAN C shares.
Address: C/O PHARMION CORPORATION 2525 28TH STREET BOULDER 80301CO
IVERS-READ GILLIAN C is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
PHRM | PHARMION CORP | VP-Clinical Dev.& Reg. Affairs, VP, Clin. Dev. & Reg. Affairs, Vice President | 0 | 0.00 |
BPTH | BIO-PATH HOLDINGS INC | Director | 0 | 0.00 |
CLVS | Clovis Oncology, Inc. | See Remarks | 248,828 | 14,929,680.00 |
Insider Trading Transactions of IVERS-READ GILLIAN C
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
May 04 2021 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 3,749 | 0 | 248,828 |
May 04 2021 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 5.54 | 1,769 | 9,800 | 247,059 |
May 04 2021 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 4,625 | 0 | 251,684 |
May 04 2021 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 5.54 | 2,183 | 12,094 | 249,501 |
May 04 2021 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 3,749 | 0 | 26,245 |
May 04 2021 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 4,625 | 0 | 50,875 |
Dec 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 233,915 |
Dec 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 5.68 | 829 | 4,709 | 233,086 |
Dec 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 0 |
Dec 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 233,915 |
Dec 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 5.68 | 829 | 4,709 | 233,086 |
Dec 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 0 |
Dec 14 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 3.28 | 68,965 | 226,205 | 284,487 |
Dec 14 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 4.81 | 52,447 | 252,270 | 232,040 |
Dec 14 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 3.28 | 68,965 | 226,205 | 0 |
Dec 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 215,416 |
Dec 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 215,416 |
Dec 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 4.89 | 277 | 1,355 | 215,139 |
Dec 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 4.89 | 277 | 1,355 | 215,139 |
Dec 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 687 | 0 | 215,826 |
Dec 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 687 | 0 | 215,826 |
Dec 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 4.89 | 304 | 1,487 | 215,522 |
Dec 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 4.89 | 304 | 1,487 | 215,522 |
Dec 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 625 |
Dec 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 625 |
Dec 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 687 | 0 | 3,438 |
Dec 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 687 | 0 | 3,438 |
Nov 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 3,749 | 0 | 216,480 |
Nov 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 4.93 | 1,689 | 8,327 | 214,791 |
Nov 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 3,749 | 0 | 33,744 |
Sep 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 213,569 |
Sep 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 6.86 | 9 | 62 | 213,560 |
Sep 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 6.85 | 829 | 5,679 | 212,731 |
Sep 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 1,875 |
Sep 08 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 211,559 |
Sep 08 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 5.30 | 263 | 1,394 | 211,296 |
Sep 08 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 688 | 0 | 211,984 |
Sep 08 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 5.30 | 290 | 1,537 | 211,694 |
Sep 08 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 1,250 |
Sep 08 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 688 | 0 | 4,125 |
Aug 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 3,749 | 0 | 212,604 |
Aug 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 5.92 | 1,670 | 9,886 | 210,934 |
Aug 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 3,749 | 0 | 37,493 |
Jun 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 209,684 |
Jun 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 6.74 | 829 | 5,587 | 208,855 |
Jun 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 3,750 |
Jun 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 207,720 |
Jun 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 7.03 | 285 | 2,004 | 207,435 |
Jun 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 687 | 0 | 208,122 |
Jun 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 7.03 | 313 | 2,200 | 207,809 |
Jun 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 1,875 |
Jun 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 687 | 0 | 4,813 |
May 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 3,749 | 0 | 208,570 |
May 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 8.10 | 1,475 | 11,948 | 207,095 |
May 07 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 3,749 | 0 | 41,242 |
Mar 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 205,650 |
Mar 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 4.60 | 829 | 3,813 | 204,821 |
Mar 23 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 5,625 |
Mar 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 203,692 |
Mar 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 7.20 | 288 | 2,074 | 203,404 |
Mar 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 688 | 0 | 204,092 |
Mar 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 7.20 | 317 | 2,282 | 203,775 |
Mar 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 2,500 |
Mar 05 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 688 | 0 | 5,500 |
Feb 06 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 14,997 | 0 | 210,271 |
Feb 06 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 8.41 | 7,204 | 60,586 | 203,067 |
Feb 06 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 14,997 | 0 | 44,991 |
Jan 31 2020 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 74,000 | 0 | 74,000 |
Dec 26 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 196,104 |
Dec 26 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 11.30 | 830 | 9,379 | 195,274 |
Dec 26 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 7,500 |
Dec 05 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 194,134 |
Dec 05 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 14.60 | 282 | 4,117 | 193,852 |
Dec 05 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 687 | 0 | 194,539 |
Dec 05 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 14.59 | 310 | 4,523 | 194,229 |
Dec 05 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 3,125 |
Dec 05 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 687 | 0 | 6,188 |
Sep 24 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 194,346 |
Sep 24 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 194,346 |
Sep 24 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 4.80 | 837 | 4,018 | 193,509 |
Sep 24 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 4.80 | 837 | 4,018 | 193,509 |
Sep 24 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 9,375 |
Sep 24 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 9,375 |
Sep 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 192,413 |
Sep 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 5.21 | 300 | 1,563 | 192,113 |
Sep 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 688 | 0 | 192,801 |
Sep 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 5.21 | 330 | 1,719 | 192,471 |
Sep 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 3,750 |
Sep 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 688 | 0 | 6,875 |
Jun 24 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 192,617 |
Jun 24 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 14.70 | 829 | 12,186 | 191,788 |
Jun 24 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 11,250 |
Jun 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 190,632 |
Jun 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 15.07 | 275 | 4,144 | 190,357 |
Jun 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 687 | 0 | 191,044 |
Jun 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 15.07 | 302 | 4,551 | 190,742 |
Jun 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 4,375 |
Jun 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 687 | 0 | 7,563 |
Jun 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 190,632 |
Jun 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 15.07 | 275 | 4,144 | 190,357 |
Jun 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 687 | 0 | 191,044 |
Jun 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 15.07 | 302 | 4,551 | 190,742 |
Jun 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 4,375 |
Jun 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 687 | 0 | 7,563 |
Mar 21 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 190,837 |
Mar 21 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 26.13 | 830 | 21,688 | 190,007 |
Mar 21 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 13,125 |
Mar 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 187,823 |
Mar 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 29.29 | 316 | 9,256 | 187,507 |
Mar 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 2,750 | 0 | 190,257 |
Mar 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 29.29 | 1,295 | 37,931 | 188,962 |
Mar 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 5,000 |
Mar 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 2,750 | 0 | 8,250 |
Mar 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 187,823 |
Mar 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 29.29 | 316 | 9,256 | 187,507 |
Mar 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 2,750 | 0 | 190,257 |
Mar 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 29.29 | 1,295 | 37,931 | 188,962 |
Mar 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 5,000 |
Mar 06 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 2,750 | 0 | 8,250 |
Feb 04 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 25.75 | 19,996 | 514,897 | 19,996 |
Feb 04 2019 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 59,988 | 0 | 59,988 |
Dec 26 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 188,027 |
Dec 26 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 17.72 | 829 | 14,690 | 187,198 |
Dec 26 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 15,000 |
Dec 06 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 186,402 |
Dec 06 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 186,402 |
Dec 06 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 21.23 | 250 | 5,308 | 186,152 |
Dec 06 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 21.23 | 250 | 5,308 | 186,152 |
Dec 06 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 5,625 |
Dec 06 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 5,625 |
Sep 24 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 186,606 |
Sep 24 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 32.21 | 829 | 26,702 | 185,777 |
Sep 24 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 16,875 |
Sep 07 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 185,013 |
Sep 07 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 35.75 | 282 | 10,082 | 184,731 |
Sep 07 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 6,250 |
Jun 21 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 185,217 |
Jun 21 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 45.75 | 829 | 37,927 | 184,388 |
Jun 21 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 18,750 |
Jun 08 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 625 | 0 | 183,620 |
Jun 08 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 47.70 | 278 | 13,261 | 183,342 |
Jun 08 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 625 | 0 | 6,875 |
Mar 21 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 1,875 | 0 | 183,824 |
Mar 21 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 56.75 | 829 | 47,046 | 182,995 |
Mar 21 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 1,875 | 0 | 20,625 |
Mar 07 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 2,500 | 0 | 183,071 |
Mar 07 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 58.43 | 1,122 | 65,558 | 181,949 |
Mar 07 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 2,500 | 0 | 7,500 |
Mar 02 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 58.43 | 11,000 | 642,730 | 11,000 |
Mar 02 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 11,000 | 0 | 11,000 |
Feb 16 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 54.09 | 3,000 | 162,270 | 180,571 |
Jan 17 2018 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 59.16 | 3,000 | 177,480 | 183,571 |
Dec 21 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Buy | 0.00 | 7,500 | 0 | 190,083 |
Dec 21 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 63.80 | 3,512 | 224,066 | 186,571 |
Dec 21 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 7,500 | 0 | 22,500 |
Dec 18 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 64.16 | 3,000 | 192,480 | 182,583 |
Nov 16 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 63.70 | 3,000 | 191,100 | 185,583 |
Oct 17 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 84.54 | 3,000 | 253,620 | 188,583 |
Sep 18 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 69.50 | 3,000 | 208,500 | 191,583 |
Aug 15 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 70.05 | 3,000 | 210,150 | 194,583 |
Jul 17 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 91.56 | 3,000 | 274,680 | 197,583 |
Jun 15 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 61.82 | 3,000 | 185,460 | 200,583 |
May 15 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 47.39 | 3,000 | 142,170 | 203,583 |
Apr 17 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 56.02 | 3,000 | 168,060 | 206,583 |
Mar 28 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 68.31 | 20,000 | 1,366,200 | 20,000 |
Mar 28 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 10,000 | 0 | 10,000 |
Mar 15 2017 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 66.99 | 3,000 | 200,970 | 209,583 |
Dec 19 2016 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 0.00 | 30,000 | 0 | 30,000 |
Sep 19 2016 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 79.05 | 8,750 | 691,688 | 26,250 |
Oct 16 2015 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 91.91 | 3,000 | 275,730 | 212,583 |
Sep 22 2015 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Sell | 112.56 | 3,000 | 337,680 | 215,583 |
Mar 04 2015 | CLVS | Clovis Oncology, Inc. | IVERS-READ GILLIAN C | See Remarks | Option Exercise | 79.05 | 35,000 | 2,766,750 | 35,000 |
Aug 17 2011 | BPTH | BIO-PATH HOLDINGS INC | IVERS-READ GILLIAN C | Director | Option Exercise | 0.33 | 25,000 | 8,250 | 25,000 |
Dec 14 2005 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 18.37 | 3,050 | 56,029 | 4,600 |
Dec 14 2005 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 18.39 | 1,600 | 29,424 | 3,000 |
Dec 14 2005 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 18.41 | 200 | 3,682 | 2,800 |
Dec 14 2005 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 18.42 | 900 | 16,578 | 1,900 |
Dec 14 2005 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 18.43 | 300 | 5,529 | 1,600 |
Dec 14 2005 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 18.44 | 400 | 7,376 | 1,200 |
Dec 14 2005 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 18.45 | 100 | 1,845 | 1,100 |
Dec 14 2005 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 18.47 | 600 | 11,082 | 500 |
Dec 14 2005 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 18.48 | 400 | 7,392 | 100 |
Dec 14 2005 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 18.50 | 100 | 1,850 | 0 |
Dec 07 2005 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | VP-Clinical Dev.& Reg ... | Option Exercise | 18.49 | 60,000 | 1,109,400 | 60,000 |
Dec 16 2004 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Buy | 1.60 | 7,650 | 12,240 | 7,650 |
Dec 16 2004 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Option Exercise | 1.60 | 7,650 | 12,240 | 17,350 |
Dec 13 2004 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Buy | 2.40 | 31,250 | 75,000 | 31,250 |
Dec 13 2004 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 45.60 | 2,000 | 91,200 | 29,250 |
Dec 13 2004 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 45.59 | 1,000 | 45,590 | 28,250 |
Dec 13 2004 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 45.57 | 800 | 36,456 | 27,450 |
Dec 13 2004 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 45.55 | 5,000 | 227,750 | 22,450 |
Dec 13 2004 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 45.53 | 2,450 | 111,549 | 20,000 |
Dec 13 2004 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Sell | 45.50 | 20,000 | 910,000 | 0 |
Dec 13 2004 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | Vice President | Option Exercise | 2.40 | 31,250 | 75,000 | 56,250 |
Dec 13 2004 | PHRM | PHARMION CORP | IVERS-READ GILLIAN C | VP, Clin. Dev. & Reg. ... | Option Exercise | 42.34 | 18,750 | 793,875 | 18,750 |